Additional data to be presented examining the safety and tolerability of AUSTEDO during periods of titration and maintenance “Tardive dyskinesia causes involuntarily, uncontrollable movements, that ...
START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia (TD), including utilization and patient satisfaction AUSTEDO is the ...
92% of patients with Huntington's disease (HD) chorea achieved optimal dosing by week 12 with treatment on the AUSTEDO 4-week patient titration kit according to early results from the START study ...
People with uncontrolled movement problems can have a harder time doing everyday tasks such as speaking, reading, writing, and cooking, which can cause a loss of independence. This may cause people to ...
Deutetrabenazine 6mg, 12mg, 18mg, 24mg, 30mg, 36mg, 42mg, 48mg; ext-rel tabs. Swallow whole. Take with or without food. Individualize. Initially 12mg once daily; may titrate at weekly intervals by 6mg ...
In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results